Clinical Trials Logo

Filter by:
NCT ID: NCT04102254 Withdrawn - Epilepsy Clinical Trials

Thalamic Stimulation for Epilepsy Study

Start date: January 7, 2023
Phase: N/A
Study type: Interventional

In this study, the investigator aims to perform cortical stereo electroencephalogram (sEEG) recordings during simultaneous anterior nucleus of the thalamus (ANT) recording and stimulation to better understand the following: 1) how the ANT is involved in various seizure types; 2) which cortical regions are modulated by established ANT stimulation patterns; and 3) how novel ANT stimulation patterns modify epileptogenic cortical activity. Together, this knowledge will advance ANT deep brain stimulation (DBS) therapy by providing a physiologic basis for patient selection for ANT DBS, while identifying brain signals and stimulation patterns that can be used to develop novel methods for ANT DBS. Up to 15 adult patients (18 and older) who present to Duke Neurosurgery for routine seizure localization using sEEG will be asked to enroll in this pilot study of ANT recording and stimulation. In the course of surgical epilepsy treatment, patients routinely undergo surgical placement of sEEG electrodes for the purposes of seizure localization. During this procedure, 2 additional leads will be placed in the ANT. These patients remain hospitalized for 7-14 days after sEEG placement, during which time their seizure medications are tapered. Concurrent video monitoring is performed while continuous neural recordings are made through the sEEG electrodes. Additionally, continuous recordings will be performed through the electrodes placed in the thalamus. Periodically, standard intermittent high-frequency stimulation (130 Hz, 90-ms pulse width, and 2 mA intensity) will be performed with a 60-s on and a 300-s off cycle after surgery. These standard ANT stimulation parameters are employed clinically. Data will include the sEEG recordings marked for ANT stimulation, any side effects, medications, past medical history (PMH), and tests/procedures during the hospital stay. Risks involved are as described for the standard depth electrode surgery with the addition of the possible side effects from the stimulation which include sensations of numbness and tingling, and possibly increased seizure activity.

NCT ID: NCT04101513 Withdrawn - Parkinson Disease Clinical Trials

The Natural History of Parkinson's Disease-associated Spinal Disorders

Start date: February 14, 2019
Phase:
Study type: Observational

This is a prospective single-institution longitudinal study to access quality of life and serial imaging and biodynamic testing to assess spinal disorders associated with Parkinson's disease patients.

NCT ID: NCT04099446 Withdrawn - Melanoma (Skin) Clinical Trials

A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer

Start date: October 2019
Phase:
Study type: Observational

This study seeks to correlate microbial sequencing data from a punch biopsy in patients with skin cancer both melanoma and non-melanoma.

NCT ID: NCT04099355 Withdrawn - Arthropathy of Knee Clinical Trials

Investigating the Effect of Dronabinol on Post-surgical Pain

Start date: September 1, 2025
Phase: Early Phase 1
Study type: Interventional

This study is designed to investigate the effect of dronabinol on post operative pain in patients undergoing total knee replacement (for their own clinical care).

NCT ID: NCT04096703 Withdrawn - Clinical trials for Esophagogastric Junction Disorder

Idiopathic Esophagogastric Junction Outflow Obstruction

Start date: October 2021
Phase: N/A
Study type: Interventional

This study compares two treatments for Idiopathic Esophagogastric Junction Outflow Obstruction: pneumatic dilation compared with expectant management, on symptoms and liquid barium emptying exams.

NCT ID: NCT04094948 Withdrawn - Clinical trials for Pompe Disease (Late-onset)

Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease

Start date: January 1, 2023
Phase: Phase 2
Study type: Interventional

The goals of this study are to determine safety and efficacy with regard to motor function of oral clenbuterol in combination with ERT in subjects with LOPD

NCT ID: NCT04094792 Withdrawn - Depression Clinical Trials

Depression, Trauma, and Health: Efficacy of an mHealth App for Symptom Self-Management in College Students

DepTH
Start date: November 5, 2019
Phase: N/A
Study type: Interventional

The study is designed to examine the efficacy of a mobile application heart rate variability biofeedback exercise on heart rate variability and depression. The main objective of this study is to assess the Breather app manufactured by Happify, Inc., as a tool for improving levels of depression and heart rate variability in college students.Happifyâ„¢ Breather is a mobile app that provides users with HRV biofeedback aimed at improving mental health and wellness. Breather uses HRV sensors to help users control breathing, leading to calm and relaxation. The more relaxed users are, the more visually reinforcing scene elements will appear in the underwater environment of the game. Breather uses an optical sensor in a smartphone camera. During app use, users are cued by the app to breathe at 6 cycles/minute using a breath pacer. When the smartphone camera flash is illuminated, color signal changes are measured from the fingertip pressed to the camera lens. The study population is college students who score in the clinical range on the PHQ-9. Secondary outcomes include anxiety, somatoform symptoms, and app adherence.

NCT ID: NCT04091594 Withdrawn - Cerebral Palsy Clinical Trials

Investigating the Effects of Sensory Input Orthotics in Disorders of Posture and Movement

Start date: January 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to use tools for measuring function and movement in pediatric populations to measure the impact of input orthotic interventions in children with cerebral palsy.

NCT ID: NCT04090853 Withdrawn - Clinical trials for Subcutaneous Fat Disorder

Subject Evaluation of a 1064nm Diode Laser/RF

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Open-label, baseline-controlled, multi-center study evaluating a 1064 nm diode laser, pulsed electromagnetic fields and vacuum assisted radio frequency for non-invasive fat reduction of the abdomen and flanks.

NCT ID: NCT04089852 Withdrawn - Analgesia Clinical Trials

Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women

Start date: June 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This pilot study aims to assess the feasibility, acceptability, and effectiveness of using nitrous oxide (N2O) sedation for intrauterine device (IUD) insertions for nulliparous adolescent and young adult women in a primary care clinic setting.